Related Experiment Video
Updated: Jul 11, 2026

08:04
Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
Finding drug targets through analysis of the platelet transcriptome
1UCD Conway Institute for Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland. james.mcredmond@ucd.ie
Current Pharmaceutical Design
|September 28, 2007
Summary
Modern transcriptome analysis reveals novel drug targets within platelets, including receptors and signaling proteins, crucial for treating thrombosis and atherogenesis.
Area of Science:
- Hematology
- Molecular Biology
- Pharmacology
Background:
- Platelets possess a complex transcriptome, analyzable with modern techniques.
- Thousands of distinct transcripts exist in platelets, including previously undescribed ones.
- Abundant messages for receptors, signal transduction proteins, and cytokines are found in platelets.
Purpose of the Study:
- To identify and characterize novel platelet drug targets.
- To explore potential therapeutic strategies for thrombosis and atherogenesis.
- To leverage transcriptional studies for drug discovery in platelets.
Main Methods:
- Analysis of the platelet transcriptome using modern techniques.
- Differential expression analysis of platelet transcripts.
- Correlation of transcript abundance with protein levels.
Main Results:
- Identification of numerous novel platelet transcripts.
- Discovery of differences in message abundance between groups.
- Confirmation that transcript differences are reflected at the protein level.
- Platelets are enriched in messages for key functional proteins.
Conclusions:
- Platelet transcriptional studies are effective for identifying novel drug targets.
- Novel receptors and signal transduction proteins represent potential drug targets.
- Proteins translated after platelet activation offer new therapeutic avenues for thrombosis and atherogenesis.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

